Faes Farma, S.A. (BME:FAE)
4.740
-0.050 (-1.04%)
Dec 5, 2025, 12:02 PM CET
Faes Farma Revenue
Faes Farma had revenue of 146.61M EUR in the quarter ending September 30, 2025, with 22.94% growth. This brings the company's revenue in the last twelve months to 571.12M, up 13.31% year-over-year. In the year 2024, Faes Farma had annual revenue of 510.04M with 7.81% growth.
Revenue (ttm)
571.12M
Revenue Growth
+13.31%
P/S Ratio
2.61
Revenue / Employee
301.54K
Employees
1,775
Market Cap
1.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 510.04M | 36.95M | 7.81% |
| Dec 31, 2023 | 473.09M | 11.38M | 2.46% |
| Dec 31, 2022 | 461.72M | 33.08M | 7.72% |
| Dec 31, 2021 | 428.64M | 17.15M | 4.17% |
| Dec 31, 2020 | 411.49M | 28.30M | 7.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.09B |
| Laboratorios Farmaceuticos Rovi | 724.20M |
| Laboratorio Reig Jofre | 330.34M |
| Clínica Baviera | 296.76M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |
| Pharma Mar | 179.28M |